Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans

Summary objective  Acylated ghrelin, a gastric peptide, possesses a potent GH‐ but also significant ACTH/cortisol‐releasing activity mediated by the activation of GH secretagogue receptors (GHS‐R) at the hypothalamus–pituitary level. The physiological role of ghrelin in the control of somatotroph an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical endocrinology (Oxford) 2004-06, Vol.60 (6), p.699-704
Hauptverfasser: Broglio, Fabio, Prodam, Flavia, Gottero, Cristina, Destefanis, Silvia, Me, Elisa, Riganti, Fabrizio, Giordano, Roberta, Picu, Andreea, Balbo, Marcella, Van der Lely, Aart Jan, Ghigo, Ezio, Arvat, Emanuela
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 704
container_issue 6
container_start_page 699
container_title Clinical endocrinology (Oxford)
container_volume 60
creator Broglio, Fabio
Prodam, Flavia
Gottero, Cristina
Destefanis, Silvia
Me, Elisa
Riganti, Fabrizio
Giordano, Roberta
Picu, Andreea
Balbo, Marcella
Van der Lely, Aart Jan
Ghigo, Ezio
Arvat, Emanuela
description Summary objective  Acylated ghrelin, a gastric peptide, possesses a potent GH‐ but also significant ACTH/cortisol‐releasing activity mediated by the activation of GH secretagogue receptors (GHS‐R) at the hypothalamus–pituitary level. The physiological role of ghrelin in the control of somatotroph and corticotroph function is, however, largely unclear. Glucagon is known to induce a clear increase of GH, ACTH and cortisol levels in humans, at least after intramuscular administration. In fact, glucagon is considered to be a classical alternative to insulin‐induced hypoglycaemia (ITT) for the combined evaluation of the function of GH and the hypothalamus–pituitary–adrenal (HPA) axis. We aimed to clarify whether ghrelin mediate the GH and corticotroph responses to intramuscular glucagon or ITT, which has recently been reported able to induce a surprising ghrelin decrease. subjects  To this aim we enrolled six normal young male subjects [age (mean ± SD): 29·0 ± 8·0 years, body mass index (BMI) 21·9 ± 2·5 kg/m2]. design and measurements  In all the subjects we studied ghrelin, GH, ACTH, cortisol and glucose levels after glucagon (GLU; 0·017 mg/kg intramuscularly), ITT (0·1 IU/kg insulin intravenously) or saline administration. results  Saline infusion was not followed by any significant variation in ghrelin, GH and glucose levels while ACTH and cortisol showed the expected spontaneous morning trend toward a decrease. GLU administration increased (P 
doi_str_mv 10.1111/j.1365-2265.2004.02038.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_198822607</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>656520631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4608-930ab7cda5792845d9f1f2dc00db2a4bfc492d9bed085fae0e9abca8480d3a363</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhS0EotPCKyALiWXCTZwfZ8ECDWWKqMoGBGJjObYz8ZDEwXbE5D144DokKiy5G1u-37nXOgchnECchHp9ihNS5FGaFnmcAmQxpEBofH6Edg-Nx2gHBCCCosgu0KVzJwDIKZRP0UWSJwUJtUO_D61VnR6wNMrhwXjcK6m5V9i3CjvTc2-8NWOL-SCxMNZrsT1Y5UYzuCDzZqW97qcuCOyMVdMo4bFp8LGbBD-aARuL9eCmsCzSg5yEkridR3PsZsFVr3no4nbq-eCeoScN75x6vp1X6Mv768_7m-j20-HD_u1tJLICaFQR4HUpJM_LKqVZLqsmaVIpAGSd8qxuRFalsqqVBJo3XIGqeC04zShIwklBrtDLde5ozc9JOc9OZrJDWMmSitLgIpQBoiskrHHOqoaNVvfcziwBtqTBTmwxnS2msyUN9icNdg7SF9v8qQ62_hVu9gfg1QZwJ3jXWD4I7f7hyopCmgfuzcr90p2a__sDbH99t9yCPlr12nl1ftBz-4MVJSlz9vXuwEry_Rt9d_OREXIPr6K4sw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198822607</pqid></control><display><type>article</type><title>Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Broglio, Fabio ; Prodam, Flavia ; Gottero, Cristina ; Destefanis, Silvia ; Me, Elisa ; Riganti, Fabrizio ; Giordano, Roberta ; Picu, Andreea ; Balbo, Marcella ; Van der Lely, Aart Jan ; Ghigo, Ezio ; Arvat, Emanuela</creator><creatorcontrib>Broglio, Fabio ; Prodam, Flavia ; Gottero, Cristina ; Destefanis, Silvia ; Me, Elisa ; Riganti, Fabrizio ; Giordano, Roberta ; Picu, Andreea ; Balbo, Marcella ; Van der Lely, Aart Jan ; Ghigo, Ezio ; Arvat, Emanuela</creatorcontrib><description>Summary objective  Acylated ghrelin, a gastric peptide, possesses a potent GH‐ but also significant ACTH/cortisol‐releasing activity mediated by the activation of GH secretagogue receptors (GHS‐R) at the hypothalamus–pituitary level. The physiological role of ghrelin in the control of somatotroph and corticotroph function is, however, largely unclear. Glucagon is known to induce a clear increase of GH, ACTH and cortisol levels in humans, at least after intramuscular administration. In fact, glucagon is considered to be a classical alternative to insulin‐induced hypoglycaemia (ITT) for the combined evaluation of the function of GH and the hypothalamus–pituitary–adrenal (HPA) axis. We aimed to clarify whether ghrelin mediate the GH and corticotroph responses to intramuscular glucagon or ITT, which has recently been reported able to induce a surprising ghrelin decrease. subjects  To this aim we enrolled six normal young male subjects [age (mean ± SD): 29·0 ± 8·0 years, body mass index (BMI) 21·9 ± 2·5 kg/m2]. design and measurements  In all the subjects we studied ghrelin, GH, ACTH, cortisol and glucose levels after glucagon (GLU; 0·017 mg/kg intramuscularly), ITT (0·1 IU/kg insulin intravenously) or saline administration. results  Saline infusion was not followed by any significant variation in ghrelin, GH and glucose levels while ACTH and cortisol showed the expected spontaneous morning trend toward a decrease. GLU administration increased (P &lt; 0·01) circulating GH, ACTH and cortisol as well as insulin and glucose levels. ITT induced an obvious increase (P &lt; 0·01) of GH, ACTH and cortisol levels. The ITT‐induced increases in GH and ACTH, but not cortisol, levels were higher (P &lt; 0·01) than those after GLU. Circulating ghrelin levels were not modified by GLU. On the other hand, ghrelin levels underwent a transient reduction (P &lt; 0·01) after insulin‐induced hypoglycaemia. conclusions  Ghrelin does not mediate the GH and ACTH responses to glucagon or to the ITT. In fact, ghrelin levels are not modified at all by glucagon and transiently decrease during the ITT. These findings support the assumption that ghrelin does not play a major role in the physiological control of somatotroph and corticotroph function.</description><identifier>ISSN: 0300-0664</identifier><identifier>EISSN: 1365-2265</identifier><identifier>DOI: 10.1111/j.1365-2265.2004.02038.x</identifier><identifier>PMID: 15163333</identifier><identifier>CODEN: CLECAP</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adrenocorticotropic Hormone - blood ; Adrenocorticotropic Hormone - secretion ; Adult ; Biological and medical sciences ; Blood Glucose - analysis ; Endocrinopathies ; Fundamental and applied biological sciences. Psychology ; Ghrelin ; Glucagon ; Growth Hormone - blood ; Growth Hormone - secretion ; Humans ; Hydrocortisone - blood ; Hypoglycemia - chemically induced ; Hypoglycemia - physiopathology ; Hypothalamo-Hypophyseal System - drug effects ; Hypothalamo-Hypophyseal System - physiopathology ; Insulin ; Male ; Medical sciences ; Peptide Hormones - blood ; Pituitary-Adrenal System - drug effects ; Pituitary-Adrenal System - physiopathology ; Vertebrates: endocrinology</subject><ispartof>Clinical endocrinology (Oxford), 2004-06, Vol.60 (6), p.699-704</ispartof><rights>2004 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. Jun 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4608-930ab7cda5792845d9f1f2dc00db2a4bfc492d9bed085fae0e9abca8480d3a363</citedby><cites>FETCH-LOGICAL-c4608-930ab7cda5792845d9f1f2dc00db2a4bfc492d9bed085fae0e9abca8480d3a363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2265.2004.02038.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2265.2004.02038.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27902,27903,45552,45553</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15798025$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15163333$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Broglio, Fabio</creatorcontrib><creatorcontrib>Prodam, Flavia</creatorcontrib><creatorcontrib>Gottero, Cristina</creatorcontrib><creatorcontrib>Destefanis, Silvia</creatorcontrib><creatorcontrib>Me, Elisa</creatorcontrib><creatorcontrib>Riganti, Fabrizio</creatorcontrib><creatorcontrib>Giordano, Roberta</creatorcontrib><creatorcontrib>Picu, Andreea</creatorcontrib><creatorcontrib>Balbo, Marcella</creatorcontrib><creatorcontrib>Van der Lely, Aart Jan</creatorcontrib><creatorcontrib>Ghigo, Ezio</creatorcontrib><creatorcontrib>Arvat, Emanuela</creatorcontrib><title>Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans</title><title>Clinical endocrinology (Oxford)</title><addtitle>Clin Endocrinol (Oxf)</addtitle><description>Summary objective  Acylated ghrelin, a gastric peptide, possesses a potent GH‐ but also significant ACTH/cortisol‐releasing activity mediated by the activation of GH secretagogue receptors (GHS‐R) at the hypothalamus–pituitary level. The physiological role of ghrelin in the control of somatotroph and corticotroph function is, however, largely unclear. Glucagon is known to induce a clear increase of GH, ACTH and cortisol levels in humans, at least after intramuscular administration. In fact, glucagon is considered to be a classical alternative to insulin‐induced hypoglycaemia (ITT) for the combined evaluation of the function of GH and the hypothalamus–pituitary–adrenal (HPA) axis. We aimed to clarify whether ghrelin mediate the GH and corticotroph responses to intramuscular glucagon or ITT, which has recently been reported able to induce a surprising ghrelin decrease. subjects  To this aim we enrolled six normal young male subjects [age (mean ± SD): 29·0 ± 8·0 years, body mass index (BMI) 21·9 ± 2·5 kg/m2]. design and measurements  In all the subjects we studied ghrelin, GH, ACTH, cortisol and glucose levels after glucagon (GLU; 0·017 mg/kg intramuscularly), ITT (0·1 IU/kg insulin intravenously) or saline administration. results  Saline infusion was not followed by any significant variation in ghrelin, GH and glucose levels while ACTH and cortisol showed the expected spontaneous morning trend toward a decrease. GLU administration increased (P &lt; 0·01) circulating GH, ACTH and cortisol as well as insulin and glucose levels. ITT induced an obvious increase (P &lt; 0·01) of GH, ACTH and cortisol levels. The ITT‐induced increases in GH and ACTH, but not cortisol, levels were higher (P &lt; 0·01) than those after GLU. Circulating ghrelin levels were not modified by GLU. On the other hand, ghrelin levels underwent a transient reduction (P &lt; 0·01) after insulin‐induced hypoglycaemia. conclusions  Ghrelin does not mediate the GH and ACTH responses to glucagon or to the ITT. In fact, ghrelin levels are not modified at all by glucagon and transiently decrease during the ITT. These findings support the assumption that ghrelin does not play a major role in the physiological control of somatotroph and corticotroph function.</description><subject>Adrenocorticotropic Hormone - blood</subject><subject>Adrenocorticotropic Hormone - secretion</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - analysis</subject><subject>Endocrinopathies</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Ghrelin</subject><subject>Glucagon</subject><subject>Growth Hormone - blood</subject><subject>Growth Hormone - secretion</subject><subject>Humans</subject><subject>Hydrocortisone - blood</subject><subject>Hypoglycemia - chemically induced</subject><subject>Hypoglycemia - physiopathology</subject><subject>Hypothalamo-Hypophyseal System - drug effects</subject><subject>Hypothalamo-Hypophyseal System - physiopathology</subject><subject>Insulin</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Peptide Hormones - blood</subject><subject>Pituitary-Adrenal System - drug effects</subject><subject>Pituitary-Adrenal System - physiopathology</subject><subject>Vertebrates: endocrinology</subject><issn>0300-0664</issn><issn>1365-2265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhS0EotPCKyALiWXCTZwfZ8ECDWWKqMoGBGJjObYz8ZDEwXbE5D144DokKiy5G1u-37nXOgchnECchHp9ihNS5FGaFnmcAmQxpEBofH6Edg-Nx2gHBCCCosgu0KVzJwDIKZRP0UWSJwUJtUO_D61VnR6wNMrhwXjcK6m5V9i3CjvTc2-8NWOL-SCxMNZrsT1Y5UYzuCDzZqW97qcuCOyMVdMo4bFp8LGbBD-aARuL9eCmsCzSg5yEkridR3PsZsFVr3no4nbq-eCeoScN75x6vp1X6Mv768_7m-j20-HD_u1tJLICaFQR4HUpJM_LKqVZLqsmaVIpAGSd8qxuRFalsqqVBJo3XIGqeC04zShIwklBrtDLde5ozc9JOc9OZrJDWMmSitLgIpQBoiskrHHOqoaNVvfcziwBtqTBTmwxnS2msyUN9icNdg7SF9v8qQ62_hVu9gfg1QZwJ3jXWD4I7f7hyopCmgfuzcr90p2a__sDbH99t9yCPlr12nl1ftBz-4MVJSlz9vXuwEry_Rt9d_OREXIPr6K4sw</recordid><startdate>200406</startdate><enddate>200406</enddate><creator>Broglio, Fabio</creator><creator>Prodam, Flavia</creator><creator>Gottero, Cristina</creator><creator>Destefanis, Silvia</creator><creator>Me, Elisa</creator><creator>Riganti, Fabrizio</creator><creator>Giordano, Roberta</creator><creator>Picu, Andreea</creator><creator>Balbo, Marcella</creator><creator>Van der Lely, Aart Jan</creator><creator>Ghigo, Ezio</creator><creator>Arvat, Emanuela</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>200406</creationdate><title>Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans</title><author>Broglio, Fabio ; Prodam, Flavia ; Gottero, Cristina ; Destefanis, Silvia ; Me, Elisa ; Riganti, Fabrizio ; Giordano, Roberta ; Picu, Andreea ; Balbo, Marcella ; Van der Lely, Aart Jan ; Ghigo, Ezio ; Arvat, Emanuela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4608-930ab7cda5792845d9f1f2dc00db2a4bfc492d9bed085fae0e9abca8480d3a363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adrenocorticotropic Hormone - blood</topic><topic>Adrenocorticotropic Hormone - secretion</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - analysis</topic><topic>Endocrinopathies</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Ghrelin</topic><topic>Glucagon</topic><topic>Growth Hormone - blood</topic><topic>Growth Hormone - secretion</topic><topic>Humans</topic><topic>Hydrocortisone - blood</topic><topic>Hypoglycemia - chemically induced</topic><topic>Hypoglycemia - physiopathology</topic><topic>Hypothalamo-Hypophyseal System - drug effects</topic><topic>Hypothalamo-Hypophyseal System - physiopathology</topic><topic>Insulin</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Peptide Hormones - blood</topic><topic>Pituitary-Adrenal System - drug effects</topic><topic>Pituitary-Adrenal System - physiopathology</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Broglio, Fabio</creatorcontrib><creatorcontrib>Prodam, Flavia</creatorcontrib><creatorcontrib>Gottero, Cristina</creatorcontrib><creatorcontrib>Destefanis, Silvia</creatorcontrib><creatorcontrib>Me, Elisa</creatorcontrib><creatorcontrib>Riganti, Fabrizio</creatorcontrib><creatorcontrib>Giordano, Roberta</creatorcontrib><creatorcontrib>Picu, Andreea</creatorcontrib><creatorcontrib>Balbo, Marcella</creatorcontrib><creatorcontrib>Van der Lely, Aart Jan</creatorcontrib><creatorcontrib>Ghigo, Ezio</creatorcontrib><creatorcontrib>Arvat, Emanuela</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Clinical endocrinology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Broglio, Fabio</au><au>Prodam, Flavia</au><au>Gottero, Cristina</au><au>Destefanis, Silvia</au><au>Me, Elisa</au><au>Riganti, Fabrizio</au><au>Giordano, Roberta</au><au>Picu, Andreea</au><au>Balbo, Marcella</au><au>Van der Lely, Aart Jan</au><au>Ghigo, Ezio</au><au>Arvat, Emanuela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans</atitle><jtitle>Clinical endocrinology (Oxford)</jtitle><addtitle>Clin Endocrinol (Oxf)</addtitle><date>2004-06</date><risdate>2004</risdate><volume>60</volume><issue>6</issue><spage>699</spage><epage>704</epage><pages>699-704</pages><issn>0300-0664</issn><eissn>1365-2265</eissn><coden>CLECAP</coden><abstract>Summary objective  Acylated ghrelin, a gastric peptide, possesses a potent GH‐ but also significant ACTH/cortisol‐releasing activity mediated by the activation of GH secretagogue receptors (GHS‐R) at the hypothalamus–pituitary level. The physiological role of ghrelin in the control of somatotroph and corticotroph function is, however, largely unclear. Glucagon is known to induce a clear increase of GH, ACTH and cortisol levels in humans, at least after intramuscular administration. In fact, glucagon is considered to be a classical alternative to insulin‐induced hypoglycaemia (ITT) for the combined evaluation of the function of GH and the hypothalamus–pituitary–adrenal (HPA) axis. We aimed to clarify whether ghrelin mediate the GH and corticotroph responses to intramuscular glucagon or ITT, which has recently been reported able to induce a surprising ghrelin decrease. subjects  To this aim we enrolled six normal young male subjects [age (mean ± SD): 29·0 ± 8·0 years, body mass index (BMI) 21·9 ± 2·5 kg/m2]. design and measurements  In all the subjects we studied ghrelin, GH, ACTH, cortisol and glucose levels after glucagon (GLU; 0·017 mg/kg intramuscularly), ITT (0·1 IU/kg insulin intravenously) or saline administration. results  Saline infusion was not followed by any significant variation in ghrelin, GH and glucose levels while ACTH and cortisol showed the expected spontaneous morning trend toward a decrease. GLU administration increased (P &lt; 0·01) circulating GH, ACTH and cortisol as well as insulin and glucose levels. ITT induced an obvious increase (P &lt; 0·01) of GH, ACTH and cortisol levels. The ITT‐induced increases in GH and ACTH, but not cortisol, levels were higher (P &lt; 0·01) than those after GLU. Circulating ghrelin levels were not modified by GLU. On the other hand, ghrelin levels underwent a transient reduction (P &lt; 0·01) after insulin‐induced hypoglycaemia. conclusions  Ghrelin does not mediate the GH and ACTH responses to glucagon or to the ITT. In fact, ghrelin levels are not modified at all by glucagon and transiently decrease during the ITT. These findings support the assumption that ghrelin does not play a major role in the physiological control of somatotroph and corticotroph function.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>15163333</pmid><doi>10.1111/j.1365-2265.2004.02038.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-0664
ispartof Clinical endocrinology (Oxford), 2004-06, Vol.60 (6), p.699-704
issn 0300-0664
1365-2265
language eng
recordid cdi_proquest_journals_198822607
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adrenocorticotropic Hormone - blood
Adrenocorticotropic Hormone - secretion
Adult
Biological and medical sciences
Blood Glucose - analysis
Endocrinopathies
Fundamental and applied biological sciences. Psychology
Ghrelin
Glucagon
Growth Hormone - blood
Growth Hormone - secretion
Humans
Hydrocortisone - blood
Hypoglycemia - chemically induced
Hypoglycemia - physiopathology
Hypothalamo-Hypophyseal System - drug effects
Hypothalamo-Hypophyseal System - physiopathology
Insulin
Male
Medical sciences
Peptide Hormones - blood
Pituitary-Adrenal System - drug effects
Pituitary-Adrenal System - physiopathology
Vertebrates: endocrinology
title Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T09%3A31%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ghrelin%20does%20not%20mediate%20the%20somatotroph%20and%20corticotroph%20responses%20to%20the%20stimulatory%20effect%20of%20glucagon%20or%20insulin-induced%20hypoglycaemia%20in%20humans&rft.jtitle=Clinical%20endocrinology%20(Oxford)&rft.au=Broglio,%20Fabio&rft.date=2004-06&rft.volume=60&rft.issue=6&rft.spage=699&rft.epage=704&rft.pages=699-704&rft.issn=0300-0664&rft.eissn=1365-2265&rft.coden=CLECAP&rft_id=info:doi/10.1111/j.1365-2265.2004.02038.x&rft_dat=%3Cproquest_cross%3E656520631%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198822607&rft_id=info:pmid/15163333&rfr_iscdi=true